semaglutide taken off shortage list On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, compounding Semaglutide and Tirzepatide off FDA

Wegovy isnt a magic pill Weight-loss injections are most effective when combined with a healthier lifestyle

That catches people off-guard, but the behavioral methodology underneath is the most evidence-based in our list

Thyroid C-cell tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)

Your healthcare provider will test you for active EBV and CMV infections before treatment

Patients who substitute regular soda with diet soda, add high-fat condiments to meals, or graze on snacks between injections often plateau or regain weight despite medication adherence

To qualify for ODB coverage, you must have a diagnosis of type 2 diabetes and meet specific Limited Use (LU) criteria, which typically include inadequate blood sugar control despite treatment with metformin